Tara Gomes on Muck Rack

Tara Gomes

Toronto
As seen in: Color Research & Application, PLOS Medicine, PLOS ONE, Archives of Disease in Childhood, BMJ Open, The BMJ, The Globe and Mail, The Toronto Star, EurekAlert!, JAMA (The Journal of the American Medical Association) and
Epidemiologist, Scientist @ Unity Health Toronto and ICES (she/her)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tara

Contact Tara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Patterns of prescription stimulant initiation before and during the COVID-19 pandemic: a population-based time-series analysis

|
By Tara Gomes, Tianru Wang, Nevena Rebic
| Canadian Medical Association Journal
Prescribed stimulants (e.g., amphetamine salts, methylphenidate) are central nervous system agents indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) and, in certain jurisdictions, for narcolepsy and other off-label uses, including adjunctive treatment of major depressive disorder.1–4 Historically, these medications have primarily been prescribed in pediatric populations; however, over the past 2 decades, ADHD diagnoses and stimulant prescriptions among adults have...
Open in Who Shared Issue with article?

Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies

|
By Leslie Dan Faculty, Araniy Santhireswaran, Tara Gomes, Muhammad Mamdani
| PLOS ONE
Methods We registered the systematic review protocol with the PROSPERO database (CRD42024598628). This protocol follows the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines (see S2 Appendix) [37]. Amendments to the protocol during study conduct will be documented in the final systematic review publication. We expect data screening and extraction to be completed by November 2025 and results to be available by December 2025.
Open in Who Shared Issue with article?

Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

|
By Erika Lee, Tara Gomes, Aaron M Drucker, Nick Daneman
| JAMA: Journal of the American Medical Association
Key Points Question Do commonly prescribed oral antibiotics carry differential risks of cutaneous adverse drug reactions (cADRs) leading to an emergency department visit or hospitalization? Findings In this population-based, nested case-control study spanning 2 decades, sulfonamide antibiotics and cephalosporins carried the highest risk of serious cADRs relative to macrolides, followed by nitrofurantoin, penicillins, and fluoroquinolones.
Open in Who Shared Issue with article?
See all 69 licensed articles (73 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Tara

Contact Tara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified